Tag: peripheral artery disease market size

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Peripheral Artery Disease Market Revenue Outlook: What CAGR Is Expected Through 2030?

The market for peripheral artery disease treatments has demonstrated robust expansion recently, projected to increase from $4.62 billion in 2025 to $4.97 billion in 2026, reflecting a compound annual growth rate of 7.5%. This historical growth trajectory has been propelled by factors such as the widespread occurrence of peripheral artery disease, a general lack of awareness regarding its risk factors, a predominant reliance on conventional pharmaceutical approaches, insufficient availability of interventional specialists, and the disjointed nature of patient care processes.

The market for peripheral artery disease is poised for significant expansion, projected to reach $6.69 billion by 2030, exhibiting a compound annual growth rate of 7.8% during the forecast period. This upward trajectory is fueled by several key factors, including the continuous innovation in minimally invasive surgical techniques, the increasing utilization of drug-eluting balloons and stents, the proliferation of hospitals and specialized vascular treatment centers, heightened public awareness coupled with proactive early detection programs, and the growing prevalence of combination treatment strategies that incorporate both lifestyle adjustments and pharmacological interventions. Furthermore, several prominent trends are anticipated to shape this market, such as the escalating application of artificial intelligence for the early identification and risk assessment of peripheral artery disease, a greater embrace of cloud-based systems for patient health monitoring, a heightened emphasis on personalized treatment approaches guided by genetic insights, the enhanced integration of Internet of Things (IoT) devices for monitoring patients after interventions, and the broader implementation of intelligent manufacturing processes in the production of medical devices for peripheral artery disease.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

Peripheral Artery Disease Market Expansion Supported By Key Demand Factors

An increasing incidence of peripheral artery diseases is anticipated to fuel the expansion of the peripheral artery disease market, given that peripheral artery disease signifies the constriction or obstruction of arteries beyond the heart, predominantly in the legs, leading to diminished blood flow and potential adverse outcomes. Treatments for peripheral artery disease are designed to alleviate symptoms, improve mobility, and mitigate the likelihood of serious complications, thereby enhancing patient health. As an illustration, data from the American Heart Association, a non-profit entity based in the United States, indicated in June 2023 that an estimated 7 to 12 million Americans and 200 million individuals worldwide suffer from this condition. Consequently, the escalating prevalence of peripheral artery diseases is serving as a catalyst for the growth observed in the peripheral artery disease market.

Peripheral Artery Disease Market Categorization By Product Type And Application

The peripheral artery disease market covered in this report is segmented –

1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories

2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

4) By End Users: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons, Non-Drug-Eluting Balloons, Scoring Balloons, Cutting Balloons

2) By Peripheral Stents: Drug-Eluting Stents, Bare Metal Stents, Covered Stents

3) By Peripheral Catheters: Sheath Introducers, Guidewires, Diagnostic Catheters, Delivery Catheters

4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters, Permanent IVC Filters

5) By Plaque Modification Devices: Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices

6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices, Flow Restriction Devices

7) By Peripheral Accessories: Diagnostic Imaging Accessories, Accessory Kits For Interventional Procedures, Support Devices

Peripheral Artery Disease Market Growth Trends Influencing Competitive Dynamics

In the competitive peripheral artery disease (PAD) market, leading entities are prioritizing the creation of novel treatments, exemplified by drug-eluting scaffold systems that can be absorbed by the body. This innovation directly addresses the increasing need for safer, longer-lasting, and minimally invasive methods to treat blockages in arteries below the knee. Such bioresorbable scaffold technologies are engineered to re-establish blood circulation before gradually disappearing, presenting a significant benefit compared to conventional metal stents that remain permanently implanted. A notable development occurred in April 2024 when Abbott Laboratories, a prominent U.S. medical technology firm, launched the Esprit BTK Everolimus Eluting Resorbable Scaffold System. This groundbreaking dissolvable stent therapy is specifically designed for PAD located below the knee, administering everolimus to curb vessel re-stenosis while its entirely resorbable nature allows it to dissolve naturally, thereby mitigating the long-term risks tied to metallic implants. It represents a sophisticated option for clinicians, superseding conventional angioplasty or permanent stenting, and proving especially advantageous for individuals with extensive lesion lengths or severe limb ischemia. Through its integrated approach of drug dispensation and temporary structural reinforcement, the Esprit BTK System is intended to promote vessel recovery, decrease adverse events, and broaden therapeutic horizons for challenging PAD presentations.

Peripheral Artery Disease Market Company Landscape And Strategic Competition

Major companies operating in the peripheral artery disease market are Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Avinger Inc.

Access The Complete Peripheral Artery Disease Market Report:

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Artery Disease Market Geographic Distribution And Regional Opportunities

North America was the largest region in the peripheral artery disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Peripheral Artery Disease Market Expected To Change From 2026 To 2030?

The peripheral artery disease market size has shown substantial growth in recent years. It is projected to increase from $4.62 billion in 2025 to $4.97 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.5%. This historical expansion can be linked to the high prevalence of peripheral artery disease, limited awareness of PAD risk factors, reliance on traditional medications, inadequate access to interventional specialists, and fragmented patient care pathways.

The peripheral artery disease market is projected to experience substantial expansion in the coming years. Its valuation is set to reach $6.69 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. This projected growth is driven by several factors, including advancements in minimally invasive peripheral interventions, the increasing use of drug-eluting balloons and stents, the expansion of hospitals and specialized vascular clinics, heightened patient awareness and early detection efforts, and the rising application of combination therapies encompassing lifestyle adjustments and pharmacotherapy. Key trends anticipated during this period involve the increasing application of AI for early PAD diagnosis and risk stratification, a growing uptake of cloud-based patient monitoring systems, an amplified focus on genomic-guided personalized PAD treatments, greater integration of IoT devices for tracking post-intervention recovery, and the increasing implementation of smart manufacturing in the production of PAD devices.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

Which Key Drivers Are Affecting The Peripheral Artery Disease Market Development?

An increasing incidence of peripheral artery diseases is projected to drive the expansion of the peripheral artery disease market in the future. Peripheral artery disease describes the constriction or obstruction of arteries located beyond the heart, typically in the legs, which leads to diminished blood circulation and possible health issues. Treatments for peripheral artery disease aid in alleviating its symptoms, improving patient mobility, and lowering the likelihood of serious complications, thereby enhancing overall patient well-being. For example, data from June 2023, provided by the American Heart Association, a US-based nonprofit organization, indicates that approximately 7 to 12 million individuals in the United States and 200 million people globally are living with this condition. Consequently, the growing prevalence of peripheral artery diseases is fueling the development of the peripheral artery disease market.

Which Segment Types Are Examined In The Peripheral Artery Disease Market Segment Study?

The peripheral artery disease market covered in this report is segmented –

1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories

2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

4) By End Users: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons, Non-Drug-Eluting Balloons, Scoring Balloons, Cutting Balloons

2) By Peripheral Stents: Drug-Eluting Stents, Bare Metal Stents, Covered Stents

3) By Peripheral Catheters: Sheath Introducers, Guidewires, Diagnostic Catheters, Delivery Catheters

4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters, Permanent IVC Filters

5) By Plaque Modification Devices: Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices

6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices, Flow Restriction Devices

7) By Peripheral Accessories: Diagnostic Imaging Accessories, Accessory Kits For Interventional Procedures, Support Devices

What Trends Are Transforming The Peripheral Artery Disease Market?

Leading companies operating within the peripheral artery disease (PAD) market are concentrating on developing innovative solutions, such as dissolvable drug-eluting scaffold systems. This effort aims to meet the increasing demand for safer, more durable, and less invasive treatment options for arterial blockages located below the knee. These resorbable scaffold technologies are designed to restore blood flow and then gradually dissolve, offering a significant advantage over traditional permanent metallic stents. For instance, in April 2024, Abbott Laboratories, a U.S.-based medical-device company, launched the Esprit BTK Everolimus Eluting Resorbable Scaffold System, marking it as a first-of-its-kind dissolvable stent therapy for below-the-knee PAD. The system delivers everolimus, a drug that helps prevent vessel re-narrowing, while its fully resorbable structure naturally dissolves over time, thereby eliminating the long-term risks associated with metal implants. It offers physicians an advanced alternative to traditional angioplasty or permanent stenting, proving particularly beneficial for patients with long lesions or critical limb ischemia. By combining drug delivery with temporary structural support, the Esprit BTK System aims to enhance vessel healing, reduce complications, and expand treatment possibilities in complex PAD cases.

Which Players Are Part Of The Competitive Landscape Of The Peripheral Artery Disease Market?

Major companies operating in the peripheral artery disease market are Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Avinger Inc.

Get The Full Peripheral Artery Disease Market Report:

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Which Region Is The Leading Market For The Peripheral Artery Disease Market?

North America was the largest region in the peripheral artery disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Peripheral Artery Disease Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Browse Through More Reports Similar to the Global Peripheral Artery Disease Market 2026, By The Business Research Company

Peripheral Artery Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Vascular Devices And Equipment Market Report

https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report

Peripheral Neuropathy Market Report

https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Peripheral Artery Disease Market Across 2026–2030?

The peripheral artery disease market size has experienced significant expansion in recent years. It is anticipated to increase from $4.62 billion in 2025 to $4.97 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.5%. The historical growth in this market can be attributed to the high prevalence of peripheral artery disease, limited awareness of PAD risk factors, reliance on traditional medications, inadequate access to interventional specialists, and fragmented patient care pathways.

The peripheral artery disease market size is projected to experience strong growth in the next few years, reaching $6.69 billion in 2030 with a compound annual growth rate (CAGR) of 7.8%. The growth during this forecast period can be attributed to advancements in minimally invasive peripheral interventions, the increasing adoption of drug-eluting balloons and stents, the expansion of hospitals and specialty vascular clinics, rising patient awareness and early detection initiatives, and the growing use of combination therapies, including lifestyle modification and pharmacotherapy. Major trends anticipated in the forecast period include an increasing use of AI for early PAD diagnosis and risk stratification, a rising adoption of cloud-based patient monitoring systems, a growing focus on genomic-guided personalized PAD therapies, an increasing integration of IoT devices for post-intervention tracking, and a rising implementation of smart manufacturing in PAD device production.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Peripheral Artery Disease Market?

The increasing incidence of peripheral artery diseases is anticipated to fuel the expansion of the peripheral artery disease market in the coming years. Peripheral artery disease involves the narrowing or obstruction of arteries located outside the heart, primarily in the legs, leading to reduced blood flow and potential health issues. Treatment for peripheral artery disease assists in mitigating symptoms, improving mobility, and lowering the risk of severe complications, which in turn enhances patients’ overall well-being. For example, in June 2023, the American Heart Association, a US-based nonprofit organization, estimated that this condition impacts between 7 to 12 million individuals in the United States and 200 million people globally. Thus, the growing prevalence of peripheral artery diseases is a significant factor driving the growth of the peripheral artery disease market.

What Segmentation Levels Are Considered In The Peripheral Artery Disease Market?

The peripheral artery disease market covered in this report is segmented –

1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories

2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

4) By End Users: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons, Non-Drug-Eluting Balloons, Scoring Balloons, Cutting Balloons

2) By Peripheral Stents: Drug-Eluting Stents, Bare Metal Stents, Covered Stents

3) By Peripheral Catheters: Sheath Introducers, Guidewires, Diagnostic Catheters, Delivery Catheters

4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters, Permanent IVC Filters

5) By Plaque Modification Devices: Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices

6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices, Flow Restriction Devices

7) By Peripheral Accessories: Diagnostic Imaging Accessories, Accessory Kits For Interventional Procedures, Support Devices

Which Trends Are Shaping The Future Of The Peripheral Artery Disease Market?

Leading companies in the peripheral artery disease (PAD) market are concentrating on developing innovative solutions, such as dissolvable drug-eluting scaffold systems, to address the increasing demand for safer, more enduring, and less invasive treatment options for arterial blockages below the knee. These resorbable scaffold technologies are designed to restore blood flow and then gradually dissolve, offering a key advantage over traditional permanent metallic stents. For instance, in April 2024, Abbott Laboratories, a U.S.-based medical-device company, introduced the Esprit BTK Everolimus Eluting Resorbable Scaffold System, a pioneering dissolvable stent therapy specifically for below-the-knee PAD. This system delivers everolimus, a drug that aids in preventing vessel re-narrowing, while its fully resorbable structure naturally dissolves over time, thereby eliminating the long-term risks associated with metal implants. It provides physicians with an advanced alternative to traditional angioplasty or permanent stenting, particularly benefiting patients with long lesions or critical limb ischemia. By integrating drug delivery with temporary structural support, the Esprit BTK System aims to enhance vessel healing, reduce complications, and expand treatment possibilities in complex PAD cases.

Which Leading Firms Are Contributing To The Growth Of The Peripheral Artery Disease Market?

Major companies operating in the peripheral artery disease market are Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Avinger Inc.

Read the full peripheral artery disease market report here:

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Which Regions Are Projected To Dominate The Peripheral Artery Disease Market In The Coming Years?

North America was the largest region in the peripheral artery disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Peripheral Artery Disease Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12068&type=smp

Browse Through More Reports Similar to the Global Peripheral Artery Disease Market 2026, By The Business Research Company

Peripheral Artery Disease Global Market Report

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Vascular Devices And Equipment Global Market Report

https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report

Peripheral Neuropathy Global Market Report

https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the peripheral artery disease market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Peripheral Artery Disease Market expected to reach by 2030?

The market size for peripheral artery disease has shown significant expansion over the past few years. This market is projected to expand from $4.62 billion in 2025 to $4.97 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.5%. Historically, this expansion has been driven by factors such as the high prevalence of peripheral artery disease, insufficient understanding of PAD risk factors, a dependency on conventional treatments, insufficient availability of interventional specialists, and disjointed patient care systems.

The peripheral artery disease market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $6.69 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. This anticipated growth is driven by several factors, including progress in minimally invasive peripheral interventions, the increasing uptake of drug-eluting balloons and stents, the proliferation of hospitals and specialized vascular clinics, enhanced patient awareness coupled with early detection efforts, and the expanding application of combined treatment approaches such as lifestyle adjustments and pharmacotherapy. Key trends anticipated during this period encompass the expanded deployment of AI for early PAD diagnosis and risk assessment, a surge in the adoption of cloud-based patient monitoring platforms, an intensified emphasis on genomic-guided personalized PAD treatments, the growing incorporation of IoT devices for monitoring after interventions, and the increasing utilization of smart manufacturing processes in the production of PAD devices.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

What Drivers Are Driving Adoption Within The Peripheral Artery Disease Market?

The increasing incidence of peripheral artery diseases is projected to stimulate the expansion of the peripheral artery disease market in the future. This condition, peripheral artery disease, involves the constriction or obstruction of arteries located outside the heart, commonly in the legs, leading to diminished blood flow and potential health issues. Treating peripheral artery disease aids in alleviating its symptoms, boosting mobility, and lowering the likelihood of serious complications, thereby improving patients’ overall health. For example, data from June 2023, provided by the American Heart Association, a US-based nonprofit organization, indicates that an estimated 7 to 12 million individuals in the United States and 200 million people globally suffer from this condition. Consequently, the growing prevalence of peripheral artery diseases is fueling the development of the peripheral artery disease market.

What Segments Are Included Within The Peripheral Artery Disease Market?

The peripheral artery disease market covered in this report is segmented –

1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories

2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

4) By End Users: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons, Non-Drug-Eluting Balloons, Scoring Balloons, Cutting Balloons

2) By Peripheral Stents: Drug-Eluting Stents, Bare Metal Stents, Covered Stents

3) By Peripheral Catheters: Sheath Introducers, Guidewires, Diagnostic Catheters, Delivery Catheters

4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters, Permanent IVC Filters

5) By Plaque Modification Devices: Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices

6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices, Flow Restriction Devices

7) By Peripheral Accessories: Diagnostic Imaging Accessories, Accessory Kits For Interventional Procedures, Support Devices

How Are Emerging Trends Affecting The Progression Of The Peripheral Artery Disease Market?

Leading companies within the peripheral artery disease (PAD) market are concentrating on creating advanced solutions, such as dissolvable drug-eluting scaffold systems, in response to the increasing need for safer, more lasting, and less intrusive treatment methods for arterial blockages below the knee. These absorbable scaffold technologies are designed to restore proper blood flow before progressively dissolving, offering a significant improvement over conventional permanent metallic stents. For example, in April 2024, Abbott Laboratories, a medical-device company based in the U.S., launched the Esprit BTK Everolimus Eluting Resorbable Scaffold System, which represents a pioneering dissolvable stent therapy specifically for below-the-knee PAD. This system releases everolimus, a medication that helps prevent the re-narrowing of vessels, while its entirely resorbable structure naturally breaks down over time, thereby removing the long-term risks linked with metal implants. It provides medical professionals with an advanced option beyond traditional angioplasty or permanent stenting, particularly benefiting patients suffering from extended lesions or critical limb ischemia. Through its combination of drug delivery and temporary structural assistance, the Esprit BTK System aims to foster better vessel healing, decrease complications, and broaden treatment possibilities for intricate PAD conditions.

Who Are The Prominent Global Companies Shaping The Peripheral Artery Disease Market Landscape?

Major companies operating in the peripheral artery disease market are Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Avinger Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Peripheral Artery Disease Market?

North America was the largest region in the peripheral artery disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Peripheral Artery Disease Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12068&type=smp

Browse Through More Reports Similar to the Global Peripheral Artery Disease Market 2026, By The Business Research Company

Coronary Artery Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

Peripheral Arterial Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Peripheral Vascular Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model